Serveur d'exploration Covid (26 mars)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases

Identifieur interne : 000070 ( Pmc/Corpus ); précédent : 000069; suivant : 000071

18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases

Auteurs : Chunxia Qin ; Fang Liu ; Tzu-Chen Yen ; Xiaoli Lan

Source :

RBID : PMC:7080035

Abstract

Purpose

The aim of this case series is to illustrate the 18F-FDG PET/CT findings of patients with acute respiratory disease caused by COVID-19 in Wuhan, Hubei province of China.

Methods

We describe the 18F-FDG PET/CT results from four patients who were admitted to the hospital with respiratory symptoms and fever between January 13 and January 20, 2020, when the COVID-19 outbreak was still unrecognized and the virus infectivity was unknown. A retrospective review of the patients’ medical history, clinical and laboratory data, as well as imaging findings strongly suggested a diagnosis of COVID-19.

Results

All patients had peripheral ground-glass opacities and/or lung consolidations in more than two pulmonary lobes. Lung lesions were characterized by a high 18F-FDG uptake and there was evidence of lymph node involvement. Conversely, disseminated disease was absent, a finding suggesting that COVID-19 has pulmonary tropism.

Conclusions

Although 18F-FDG PET/CT cannot be routinely used in an emergency setting and is generally not recommended for infectious diseases, our pilot data shed light on the potential clinical utility of this imaging technique in the differential diagnosis of complex cases.


Url:
DOI: 10.1007/s00259-020-04734-w
PubMed: 32088847
PubMed Central: 7080035

Links to Exploration step

PMC:7080035

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">
<sup>18</sup>
F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases</title>
<author>
<name sortKey="Qin, Chunxia" sort="Qin, Chunxia" uniqKey="Qin C" first="Chunxia" last="Qin">Chunxia Qin</name>
<affiliation>
<nlm:aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="GRID">grid.33199.31</institution-id>
<institution-id institution-id-type="ISNI">0000 0004 0368 7223</institution-id>
<institution>Department of Nuclear Medicine, Union Hospital, Tongji Medical College,</institution>
<institution>Huazhong University of Science and Technology,</institution>
</institution-wrap>
No. 1277 Jiefang Ave, Wuhan, 430022 China</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff2">Hubei Province Key Laboratory of Molecular Imaging, Wuhan, 430022 China</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Liu, Fang" sort="Liu, Fang" uniqKey="Liu F" first="Fang" last="Liu">Fang Liu</name>
<affiliation>
<nlm:aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="GRID">grid.33199.31</institution-id>
<institution-id institution-id-type="ISNI">0000 0004 0368 7223</institution-id>
<institution>Department of Nuclear Medicine, Union Hospital, Tongji Medical College,</institution>
<institution>Huazhong University of Science and Technology,</institution>
</institution-wrap>
No. 1277 Jiefang Ave, Wuhan, 430022 China</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff2">Hubei Province Key Laboratory of Molecular Imaging, Wuhan, 430022 China</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Yen, Tzu Chen" sort="Yen, Tzu Chen" uniqKey="Yen T" first="Tzu-Chen" last="Yen">Tzu-Chen Yen</name>
<affiliation>
<nlm:aff id="Aff3">
<institution-wrap>
<institution-id institution-id-type="GRID">grid.145695.a</institution-id>
<institution>Department of Nuclear Medicine and Molecular Imaging Center,</institution>
<institution>Linkou Chang Gung Memorial Hospital and Chang Gung University,</institution>
</institution-wrap>
Taoyuan, Taiwan</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Lan, Xiaoli" sort="Lan, Xiaoli" uniqKey="Lan X" first="Xiaoli" last="Lan">Xiaoli Lan</name>
<affiliation>
<nlm:aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="GRID">grid.33199.31</institution-id>
<institution-id institution-id-type="ISNI">0000 0004 0368 7223</institution-id>
<institution>Department of Nuclear Medicine, Union Hospital, Tongji Medical College,</institution>
<institution>Huazhong University of Science and Technology,</institution>
</institution-wrap>
No. 1277 Jiefang Ave, Wuhan, 430022 China</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff2">Hubei Province Key Laboratory of Molecular Imaging, Wuhan, 430022 China</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">32088847</idno>
<idno type="pmc">7080035</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080035</idno>
<idno type="RBID">PMC:7080035</idno>
<idno type="doi">10.1007/s00259-020-04734-w</idno>
<date when="2020">2020</date>
<idno type="wicri:Area/Pmc/Corpus">000070</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000070</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">
<sup>18</sup>
F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases</title>
<author>
<name sortKey="Qin, Chunxia" sort="Qin, Chunxia" uniqKey="Qin C" first="Chunxia" last="Qin">Chunxia Qin</name>
<affiliation>
<nlm:aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="GRID">grid.33199.31</institution-id>
<institution-id institution-id-type="ISNI">0000 0004 0368 7223</institution-id>
<institution>Department of Nuclear Medicine, Union Hospital, Tongji Medical College,</institution>
<institution>Huazhong University of Science and Technology,</institution>
</institution-wrap>
No. 1277 Jiefang Ave, Wuhan, 430022 China</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff2">Hubei Province Key Laboratory of Molecular Imaging, Wuhan, 430022 China</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Liu, Fang" sort="Liu, Fang" uniqKey="Liu F" first="Fang" last="Liu">Fang Liu</name>
<affiliation>
<nlm:aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="GRID">grid.33199.31</institution-id>
<institution-id institution-id-type="ISNI">0000 0004 0368 7223</institution-id>
<institution>Department of Nuclear Medicine, Union Hospital, Tongji Medical College,</institution>
<institution>Huazhong University of Science and Technology,</institution>
</institution-wrap>
No. 1277 Jiefang Ave, Wuhan, 430022 China</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff2">Hubei Province Key Laboratory of Molecular Imaging, Wuhan, 430022 China</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Yen, Tzu Chen" sort="Yen, Tzu Chen" uniqKey="Yen T" first="Tzu-Chen" last="Yen">Tzu-Chen Yen</name>
<affiliation>
<nlm:aff id="Aff3">
<institution-wrap>
<institution-id institution-id-type="GRID">grid.145695.a</institution-id>
<institution>Department of Nuclear Medicine and Molecular Imaging Center,</institution>
<institution>Linkou Chang Gung Memorial Hospital and Chang Gung University,</institution>
</institution-wrap>
Taoyuan, Taiwan</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Lan, Xiaoli" sort="Lan, Xiaoli" uniqKey="Lan X" first="Xiaoli" last="Lan">Xiaoli Lan</name>
<affiliation>
<nlm:aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="GRID">grid.33199.31</institution-id>
<institution-id institution-id-type="ISNI">0000 0004 0368 7223</institution-id>
<institution>Department of Nuclear Medicine, Union Hospital, Tongji Medical College,</institution>
<institution>Huazhong University of Science and Technology,</institution>
</institution-wrap>
No. 1277 Jiefang Ave, Wuhan, 430022 China</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff2">Hubei Province Key Laboratory of Molecular Imaging, Wuhan, 430022 China</nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">European Journal of Nuclear Medicine and Molecular Imaging</title>
<idno type="ISSN">1619-7070</idno>
<idno type="eISSN">1619-7089</idno>
<imprint>
<date when="2020">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<sec>
<title>Purpose</title>
<p id="Par1">The aim of this case series is to illustrate the
<sup>18</sup>
F-FDG PET/CT findings of patients with acute respiratory disease caused by COVID-19 in Wuhan, Hubei province of China.</p>
</sec>
<sec>
<title>Methods</title>
<p id="Par2">We describe the
<sup>18</sup>
F-FDG PET/CT results from four patients who were admitted to the hospital with respiratory symptoms and fever between January 13 and January 20, 2020, when the COVID-19 outbreak was still unrecognized and the virus infectivity was unknown. A retrospective review of the patients’ medical history, clinical and laboratory data, as well as imaging findings strongly suggested a diagnosis of COVID-19.</p>
</sec>
<sec>
<title>Results</title>
<p id="Par3">All patients had peripheral ground-glass opacities and/or lung consolidations in more than two pulmonary lobes. Lung lesions were characterized by a high
<sup>18</sup>
F-FDG uptake and there was evidence of lymph node involvement. Conversely, disseminated disease was absent, a finding suggesting that COVID-19 has pulmonary tropism.</p>
</sec>
<sec>
<title>Conclusions</title>
<p id="Par4">Although
<sup>18</sup>
F-FDG PET/CT cannot be routinely used in an emergency setting and is generally not recommended for infectious diseases, our pilot data shed light on the potential clinical utility of this imaging technique in the differential diagnosis of complex cases.</p>
</sec>
</div>
</front>
<back>
<div1 type="bibliography">
<listBibl>
<biblStruct>
<analytic>
<author>
<name sortKey="Zhu, Na" uniqKey="Zhu N">Na Zhu</name>
</author>
<author>
<name sortKey="Zhang, Dingyu" uniqKey="Zhang D">Dingyu Zhang</name>
</author>
<author>
<name sortKey="Wang, Wenling" uniqKey="Wang W">Wenling Wang</name>
</author>
<author>
<name sortKey="Li, Xingwang" uniqKey="Li X">Xingwang Li</name>
</author>
<author>
<name sortKey="Yang, Bo" uniqKey="Yang B">Bo Yang</name>
</author>
<author>
<name sortKey="Song, Jingdong" uniqKey="Song J">Jingdong Song</name>
</author>
<author>
<name sortKey="Zhao, Xiang" uniqKey="Zhao X">Xiang Zhao</name>
</author>
<author>
<name sortKey="Huang, Baoying" uniqKey="Huang B">Baoying Huang</name>
</author>
<author>
<name sortKey="Shi, Weifeng" uniqKey="Shi W">Weifeng Shi</name>
</author>
<author>
<name sortKey="Lu, Roujian" uniqKey="Lu R">Roujian Lu</name>
</author>
<author>
<name sortKey="Niu, Peihua" uniqKey="Niu P">Peihua Niu</name>
</author>
<author>
<name sortKey="Zhan, Faxian" uniqKey="Zhan F">Faxian Zhan</name>
</author>
<author>
<name sortKey="Ma, Xuejun" uniqKey="Ma X">Xuejun Ma</name>
</author>
<author>
<name sortKey="Wang, Dayan" uniqKey="Wang D">Dayan Wang</name>
</author>
<author>
<name sortKey="Xu, Wenbo" uniqKey="Xu W">Wenbo Xu</name>
</author>
<author>
<name sortKey="Wu, Guizhen" uniqKey="Wu G">Guizhen Wu</name>
</author>
<author>
<name sortKey="Gao, George F" uniqKey="Gao G">George F. Gao</name>
</author>
<author>
<name sortKey="Tan, Wenjie" uniqKey="Tan W">Wenjie Tan</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Huang, Chaolin" uniqKey="Huang C">Chaolin Huang</name>
</author>
<author>
<name sortKey="Wang, Yeming" uniqKey="Wang Y">Yeming Wang</name>
</author>
<author>
<name sortKey="Li, Xingwang" uniqKey="Li X">Xingwang Li</name>
</author>
<author>
<name sortKey="Ren, Lili" uniqKey="Ren L">Lili Ren</name>
</author>
<author>
<name sortKey="Zhao, Jianping" uniqKey="Zhao J">Jianping Zhao</name>
</author>
<author>
<name sortKey="Hu, Yi" uniqKey="Hu Y">Yi Hu</name>
</author>
<author>
<name sortKey="Zhang, Li" uniqKey="Zhang L">Li Zhang</name>
</author>
<author>
<name sortKey="Fan, Guohui" uniqKey="Fan G">Guohui Fan</name>
</author>
<author>
<name sortKey="Xu, Jiuyang" uniqKey="Xu J">Jiuyang Xu</name>
</author>
<author>
<name sortKey="Gu, Xiaoying" uniqKey="Gu X">Xiaoying Gu</name>
</author>
<author>
<name sortKey="Cheng, Zhenshun" uniqKey="Cheng Z">Zhenshun Cheng</name>
</author>
<author>
<name sortKey="Yu, Ting" uniqKey="Yu T">Ting Yu</name>
</author>
<author>
<name sortKey="Xia, Jiaan" uniqKey="Xia J">Jiaan Xia</name>
</author>
<author>
<name sortKey="Wei, Yuan" uniqKey="Wei Y">Yuan Wei</name>
</author>
<author>
<name sortKey="Wu, Wenjuan" uniqKey="Wu W">Wenjuan Wu</name>
</author>
<author>
<name sortKey="Xie, Xuelei" uniqKey="Xie X">Xuelei Xie</name>
</author>
<author>
<name sortKey="Yin, Wen" uniqKey="Yin W">Wen Yin</name>
</author>
<author>
<name sortKey="Li, Hui" uniqKey="Li H">Hui Li</name>
</author>
<author>
<name sortKey="Liu, Min" uniqKey="Liu M">Min Liu</name>
</author>
<author>
<name sortKey="Xiao, Yan" uniqKey="Xiao Y">Yan Xiao</name>
</author>
<author>
<name sortKey="Gao, Hong" uniqKey="Gao H">Hong Gao</name>
</author>
<author>
<name sortKey="Guo, Li" uniqKey="Guo L">Li Guo</name>
</author>
<author>
<name sortKey="Xie, Jungang" uniqKey="Xie J">Jungang Xie</name>
</author>
<author>
<name sortKey="Wang, Guangfa" uniqKey="Wang G">Guangfa Wang</name>
</author>
<author>
<name sortKey="Jiang, Rongmeng" uniqKey="Jiang R">Rongmeng Jiang</name>
</author>
<author>
<name sortKey="Gao, Zhancheng" uniqKey="Gao Z">Zhancheng Gao</name>
</author>
<author>
<name sortKey="Jin, Qi" uniqKey="Jin Q">Qi Jin</name>
</author>
<author>
<name sortKey="Wang, Jianwei" uniqKey="Wang J">Jianwei Wang</name>
</author>
<author>
<name sortKey="Cao, Bin" uniqKey="Cao B">Bin Cao</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Chen, Nanshan" uniqKey="Chen N">Nanshan Chen</name>
</author>
<author>
<name sortKey="Zhou, Min" uniqKey="Zhou M">Min Zhou</name>
</author>
<author>
<name sortKey="Dong, Xuan" uniqKey="Dong X">Xuan Dong</name>
</author>
<author>
<name sortKey="Qu, Jieming" uniqKey="Qu J">Jieming Qu</name>
</author>
<author>
<name sortKey="Gong, Fengyun" uniqKey="Gong F">Fengyun Gong</name>
</author>
<author>
<name sortKey="Han, Yang" uniqKey="Han Y">Yang Han</name>
</author>
<author>
<name sortKey="Qiu, Yang" uniqKey="Qiu Y">Yang Qiu</name>
</author>
<author>
<name sortKey="Wang, Jingli" uniqKey="Wang J">Jingli Wang</name>
</author>
<author>
<name sortKey="Liu, Ying" uniqKey="Liu Y">Ying Liu</name>
</author>
<author>
<name sortKey="Wei, Yuan" uniqKey="Wei Y">Yuan Wei</name>
</author>
<author>
<name sortKey="Xia, Jia An" uniqKey="Xia J">Jia'an Xia</name>
</author>
<author>
<name sortKey="Yu, Ting" uniqKey="Yu T">Ting Yu</name>
</author>
<author>
<name sortKey="Zhang, Xinxin" uniqKey="Zhang X">Xinxin Zhang</name>
</author>
<author>
<name sortKey="Zhang, Li" uniqKey="Zhang L">Li Zhang</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Prabhu, M" uniqKey="Prabhu M">M Prabhu</name>
</author>
<author>
<name sortKey="Raju, S" uniqKey="Raju S">S Raju</name>
</author>
<author>
<name sortKey="Chakraborty, D" uniqKey="Chakraborty D">D Chakraborty</name>
</author>
<author>
<name sortKey="Arora, S" uniqKey="Arora S">S Arora</name>
</author>
<author>
<name sortKey="Kumar, R" uniqKey="Kumar R">R Kumar</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Jacobson, Fl" uniqKey="Jacobson F">FL Jacobson</name>
</author>
<author>
<name sortKey="Tarascio, Jn" uniqKey="Tarascio J">JN Tarascio</name>
</author>
<author>
<name sortKey="Fox, Sw" uniqKey="Fox S">SW Fox</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Chefer, S" uniqKey="Chefer S">S Chefer</name>
</author>
<author>
<name sortKey="Thomasson, D" uniqKey="Thomasson D">D Thomasson</name>
</author>
<author>
<name sortKey="Seidel, J" uniqKey="Seidel J">J Seidel</name>
</author>
<author>
<name sortKey="Reba, Rc" uniqKey="Reba R">RC Reba</name>
</author>
<author>
<name sortKey="Bohannon, Jk" uniqKey="Bohannon J">JK Bohannon</name>
</author>
<author>
<name sortKey="Lackemeyer, Mg" uniqKey="Lackemeyer M">MG Lackemeyer</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Jonsson, Cb" uniqKey="Jonsson C">CB Jonsson</name>
</author>
<author>
<name sortKey="Camp, Jv" uniqKey="Camp J">JV Camp</name>
</author>
<author>
<name sortKey="Wu, A" uniqKey="Wu A">A Wu</name>
</author>
<author>
<name sortKey="Zheng, H" uniqKey="Zheng H">H Zheng</name>
</author>
<author>
<name sortKey="Kraenzle, Jl" uniqKey="Kraenzle J">JL Kraenzle</name>
</author>
<author>
<name sortKey="Biller, Ae" uniqKey="Biller A">AE Biller</name>
</author>
</analytic>
</biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="brief-report">
<pmc-dir>properties open_access</pmc-dir>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Eur J Nucl Med Mol Imaging</journal-id>
<journal-id journal-id-type="iso-abbrev">Eur. J. Nucl. Med. Mol. Imaging</journal-id>
<journal-title-group>
<journal-title>European Journal of Nuclear Medicine and Molecular Imaging</journal-title>
</journal-title-group>
<issn pub-type="ppub">1619-7070</issn>
<issn pub-type="epub">1619-7089</issn>
<publisher>
<publisher-name>Springer Berlin Heidelberg</publisher-name>
<publisher-loc>Berlin/Heidelberg</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32088847</article-id>
<article-id pub-id-type="pmc">7080035</article-id>
<article-id pub-id-type="publisher-id">4734</article-id>
<article-id pub-id-type="doi">10.1007/s00259-020-04734-w</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Short Communication</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>
<sup>18</sup>
F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Qin</surname>
<given-names>Chunxia</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Fang</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Yen</surname>
<given-names>Tzu-Chen</given-names>
</name>
<address>
<email>yentc1110@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7263-7399</contrib-id>
<name>
<surname>Lan</surname>
<given-names>Xiaoli</given-names>
</name>
<address>
<email>xiaoli_lan@hust.edu.cn</email>
<email>lxl730724@hotmail.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<aff id="Aff1">
<label>1</label>
<institution-wrap>
<institution-id institution-id-type="GRID">grid.33199.31</institution-id>
<institution-id institution-id-type="ISNI">0000 0004 0368 7223</institution-id>
<institution>Department of Nuclear Medicine, Union Hospital, Tongji Medical College,</institution>
<institution>Huazhong University of Science and Technology,</institution>
</institution-wrap>
No. 1277 Jiefang Ave, Wuhan, 430022 China</aff>
<aff id="Aff2">
<label>2</label>
Hubei Province Key Laboratory of Molecular Imaging, Wuhan, 430022 China</aff>
<aff id="Aff3">
<label>3</label>
<institution-wrap>
<institution-id institution-id-type="GRID">grid.145695.a</institution-id>
<institution>Department of Nuclear Medicine and Molecular Imaging Center,</institution>
<institution>Linkou Chang Gung Memorial Hospital and Chang Gung University,</institution>
</institution-wrap>
Taoyuan, Taiwan</aff>
</contrib-group>
<pub-date pub-type="epub">
<day>22</day>
<month>2</month>
<year>2020</year>
</pub-date>
<fpage>1</fpage>
<lpage>6</lpage>
<history>
<date date-type="received">
<day>10</day>
<month>2</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>2</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© Springer-Verlag GmbH Germany, part of Springer Nature 2020</copyright-statement>
<license>
<license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Purpose</title>
<p id="Par1">The aim of this case series is to illustrate the
<sup>18</sup>
F-FDG PET/CT findings of patients with acute respiratory disease caused by COVID-19 in Wuhan, Hubei province of China.</p>
</sec>
<sec>
<title>Methods</title>
<p id="Par2">We describe the
<sup>18</sup>
F-FDG PET/CT results from four patients who were admitted to the hospital with respiratory symptoms and fever between January 13 and January 20, 2020, when the COVID-19 outbreak was still unrecognized and the virus infectivity was unknown. A retrospective review of the patients’ medical history, clinical and laboratory data, as well as imaging findings strongly suggested a diagnosis of COVID-19.</p>
</sec>
<sec>
<title>Results</title>
<p id="Par3">All patients had peripheral ground-glass opacities and/or lung consolidations in more than two pulmonary lobes. Lung lesions were characterized by a high
<sup>18</sup>
F-FDG uptake and there was evidence of lymph node involvement. Conversely, disseminated disease was absent, a finding suggesting that COVID-19 has pulmonary tropism.</p>
</sec>
<sec>
<title>Conclusions</title>
<p id="Par4">Although
<sup>18</sup>
F-FDG PET/CT cannot be routinely used in an emergency setting and is generally not recommended for infectious diseases, our pilot data shed light on the potential clinical utility of this imaging technique in the differential diagnosis of complex cases.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>COVID-19</kwd>
<kwd>SARS-CoV-2</kwd>
<kwd>Infection</kwd>
<kwd>Acute respiratory disease</kwd>
<kwd>
<sup>18</sup>
F-FDG PET/CT</kwd>
<kwd>Ground-glass opacities</kwd>
<kwd>Consolidative opacities</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p id="Par5">An outbreak of acute respiratory disease caused by a novel coronavirus of zoonotic origin (SARS-CoV-2) occurred during December 2019 in Wuhan, Hubei province of China. Additional cases have been subsequently identified both in other parts of China and worldwide [
<xref ref-type="bibr" rid="CR1">1</xref>
,
<xref ref-type="bibr" rid="CR2">2</xref>
]. World Health Organization officially names the disease COVID-19 [
<xref ref-type="bibr" rid="CR3">3</xref>
]. Common clinical manifestations of COVID-19 include fever, cough, shortness of breath, myalgia, and fatigue [
<xref ref-type="bibr" rid="CR4">4</xref>
,
<xref ref-type="bibr" rid="CR5">5</xref>
]. Although detection of viral RNA remains the gold standard for diagnosis, false-negative results are not uncommon. The possible reasons may include the lack of standard operation procedures (SOPs) and validation across different laboratories for viral identification, different viral loads at different anatomical sites and high mutation rates. Consequently, clinical diagnosis is generally based on exposure history, clinical symptoms, results of blood and biochemical tests, and findings on chest computed tomography (CT)—which typically consist of ground-glass opacities (GGOs) or bilateral pulmonary consolidations in multiple lobular and sub-segmental areas [
<xref ref-type="bibr" rid="CR4">4</xref>
,
<xref ref-type="bibr" rid="CR6">6</xref>
].</p>
<p id="Par6">In general, the identification of pulmonary GGOs or patients presenting with persistent fever should prompt additional diagnostic testing for differential diagnosis—including
<sup>18</sup>
F-FDG PET/CT imaging. Here, we report the
<sup>18</sup>
F-FDG PET/CT findings from four patients who were admitted to the Wuhan Union Hospital with lung GGOs and fever between January 13 and January 20, 2020—when the COVID-19 outbreak was still unrecognized and the virus infectivity was unknown. A retrospective review of the patients’ medical history, clinical and laboratory data, as well as imaging findings (Table
<xref rid="Tab1" ref-type="table">1</xref>
) strongly suggested a diagnosis of COVID-19.
<table-wrap id="Tab1">
<label>Table 1</label>
<caption>
<p>General characteristics and PET/CT findings of four cases with COVID-19</p>
</caption>
<table frame="hsides" rules="groups">
<tbody>
<tr>
<td colspan="2">Patient number</td>
<td>1</td>
<td>2</td>
<td>3</td>
<td>4</td>
</tr>
<tr>
<td colspan="2">Sex</td>
<td>Man</td>
<td>Man</td>
<td>Woman</td>
<td>Woman</td>
</tr>
<tr>
<td colspan="2">Age, years</td>
<td>57</td>
<td>56</td>
<td>61</td>
<td>48</td>
</tr>
<tr>
<td colspan="2">Clinical symptoms</td>
<td>Fever, sore throat</td>
<td>Fever, fatigue, dizziness</td>
<td>Back pain, dry cough</td>
<td>Fever, chill, dry cough, myalgia, and fatigue</td>
</tr>
<tr>
<td colspan="2">History of staying in Wuhan</td>
<td>Yes</td>
<td>Yes</td>
<td>Yes</td>
<td>Yes</td>
</tr>
<tr>
<td colspan="2">WBC (× 10
<sup>9</sup>
/L) (reference range 3.5–9.5 × 10
<sup>9</sup>
/L)</td>
<td>Normal</td>
<td>3.33</td>
<td>3.47</td>
<td>Normal</td>
</tr>
<tr>
<td colspan="2">Lymphocytes (%) (reference range 20–40%)</td>
<td>Normal</td>
<td>17.5%</td>
<td>Normal</td>
<td>Normal</td>
</tr>
<tr>
<td colspan="2">HsCRP (mg/L) (reference range 0–5 mg/L)</td>
<td>6.65</td>
<td>23.6</td>
<td>Not available</td>
<td>12.2</td>
</tr>
<tr>
<td colspan="2">Respiratory pathogens*</td>
<td>Negative</td>
<td>Negative</td>
<td>Not available</td>
<td>Negative</td>
</tr>
<tr>
<td rowspan="6">PET/CT findings</td>
<td>Number of affected lobes</td>
<td>2 (RUL, LLL)</td>
<td>5 (all lobes)</td>
<td>3 (RUL, RLL, LLL)</td>
<td>3 (RML, RLL, LLL)</td>
</tr>
<tr>
<td>Lung CT features</td>
<td>GGO</td>
<td>GGO and consolidative opacities</td>
<td>GGO</td>
<td>GGO with interlobular septal thickening</td>
</tr>
<tr>
<td>SUVmax</td>
<td>4.6</td>
<td>7.9</td>
<td>12.2</td>
<td>9.3</td>
</tr>
<tr>
<td>LN involvement</td>
<td>Absent</td>
<td>Right subclavian region, mediastinum</td>
<td>Right supraclavicular region, mediastinum</td>
<td>Right subclavian region, mediastinum, right hilar region</td>
</tr>
<tr>
<td>LN SUVmax</td>
<td></td>
<td>7</td>
<td>5.4</td>
<td>5.5</td>
</tr>
<tr>
<td>Concomitant diseases**</td>
<td>Absent</td>
<td>Absent</td>
<td>Absent</td>
<td>Absent</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>*The following respiratory pathogens were investigated:
<italic>Mycoplasma pneumoniae</italic>
,
<italic>Chlamydia pneumoniae</italic>
, adenovirus, respiratory syncytial virus, and Coxsackie B-virus specific IgM</p>
<p>**Including malignancies and other infectious diseases</p>
<p>
<italic>WBC</italic>
, white blood cell;
<italic>hsCRP</italic>
, high-sensitivity C-reactive protein;
<italic>LN</italic>
, lymph node;
<italic>RUL</italic>
, right upper lobe;
<italic>RML</italic>
, right middle lobe;
<italic>RLL</italic>
, right lower lobe;
<italic>LUL</italic>
, left upper lobe;
<italic>LLL</italic>
, left lower lobe;
<italic>GGO</italic>
, ground-glass opacities;
<italic>SUV</italic>
, standardized uptake value</p>
</table-wrap-foot>
</table-wrap>
</p>
<sec id="FPar1">
<title>Case 1</title>
<p id="Par7">A 57-year-old man living in Wuhan presented with sore throat and fever (39.0 °C) lasting for 3 days. Laboratory testing revealed a white blood cell (WBC) count within the reference range and a slight elevation of high-sensitivity C-reactive protein (hsCRP; 6.65 mg/L, reference range 0–5 mg/L). A search for common respiratory pathogens, including
<italic>Mycoplasma pneumoniae</italic>
,
<italic>Chlamydia pneumoniae</italic>
, adenovirus, respiratory syncytial virus, and Coxsackie B-virus specific IgM, yielded negative results. A chest CT scan conducted in another hospital 2 days before revealed the presence of a GGO in the right lung, which required further diagnostic workout (differential diagnosis between a tumor and an infectious disease).
<sup>18</sup>
F-FDG PET/CT identified peripheral GGOs with an increased
<sup>18</sup>
F-FDG uptake (SUVmax range 2.2–4.6) in the right upper lung (Fig. 
<xref rid="Fig1" ref-type="fig">1a, b</xref>
, arrows) and left lower lung (Fig. 
<xref rid="Fig1" ref-type="fig">1c</xref>
; arrows). Unfortunately, SARS-CoV-2 nucleic acid testing was not performed. Antiviral, anti-inflammatory, and symptomatic treatment for 2 weeks led to complete resolution of symptoms.
<fig id="Fig1">
<label>Fig. 1</label>
<caption>
<p>Peripheral GGOs with an increased
<sup>18</sup>
F-FDG uptake in the right upper lung and left lower lung</p>
</caption>
<graphic xlink:href="259_2020_4734_Fig1_HTML" id="MO1"></graphic>
</fig>
</p>
</sec>
<sec id="FPar2">
<title>Case 2</title>
<p id="Par8">A 56-year-old man with a recent history of surgery for lung repair and rib fracture internal fixation following a traumatic event presented to hospital with an 8-day history of intermittent fever (up to 39.1 °C, more frequent in early morning and the afternoon) accompanied by fatigue and dizziness. Cough and sputum production were absent. Laboratory testing revealed mild leukopenia (WBC count 3.33 × 10
<sup>9</sup>
/L; reference range 3.5–9.5 × 10
<sup>9</sup>
/L) with 75.5% neutrophils and 17.5% lymphocytes (normal range 20–40%). Inflammatory indices, including hsCRP (23.6 mg/L) and erythrocyte sedimentation rate (73 mm/h; reference range < 15 mm/h), were increased, but a search for known respiratory pathogens yielded negative findings.
<sup>18</sup>
F-FDG PET/CT imaging (January 13, 2020) revealed multiple FDG-positive GGOs and consolidative opacities in both lungs (SUVmax range 1.8–7.9; Fig. 
<xref rid="Fig2" ref-type="fig">2a, b</xref>
, arrows). There were also multiple FDG-avid lymph nodes in the mediastinum and the subclavian region (SUVmax range 4.1–7.0; Fig. 
<xref rid="Fig2" ref-type="fig">2c</xref>
, arrows). Unfortunately, SARS-CoV-2 nucleic acid testing was not performed. The lesions on
<sup>18</sup>
F-FDG PET/CT were smaller than those detected on previous CT imaging (January 7, 2020) and regressed further after treatment (January 21, 2020; Fig. 
<xref rid="Fig2" ref-type="fig">2d</xref>
, arrows).
<fig id="Fig2">
<label>Fig. 2</label>
<caption>
<p>Multiple FDG-positive GGOs and consolidative opacities in both lungs as well as multiple FDG-avid lymph nodes in the mediastinum and the subclavian region</p>
</caption>
<graphic xlink:href="259_2020_4734_Fig2_HTML" id="MO2"></graphic>
</fig>
</p>
</sec>
<sec id="FPar3">
<title>Case 3</title>
<p id="Par9">A 61-year-old woman living in Wuhan complained of back pain and dry cough over a week. Laboratory testing revealed a mild leucopenia (WBC 3.47 × 10
<sup>9</sup>
/L). Chest CT identified an 8-mm light shadow in the right upper lung lobe and a 9-mm solid nodule in the left lower lung lobe, which initially led to a suspicion of malignancy. A week thereafter,
<sup>18</sup>
F-FDG PET/CT revealed multiple peripheral FDG-avid GGOs (SUVmax range 3.7–12.2) in the right lung (Fig. 
<xref rid="Fig3" ref-type="fig">3a, b</xref>
, arrows). Multiple FDG-positive lymph nodes were also identified in the mediastinum and the right subclavian region (SUVmax range 3.4–5.4; Fig. 
<xref rid="Fig3" ref-type="fig">3c</xref>
, arrows). We did not perform SARS-CoV-2 nucleic acid testing. An 18-day treatment with antiviral and anti-inflammatory drugs led to symptom improvement.
<fig id="Fig3">
<label>Fig. 3</label>
<caption>
<p>Multiple peripheral FDG-avid GGOs in the right lung and multiple FDG-positive nodes in the mediastinum and the right subclavian region</p>
</caption>
<graphic xlink:href="259_2020_4734_Fig3_HTML" id="MO3"></graphic>
</fig>
</p>
</sec>
<sec id="FPar4">
<title>Case 4</title>
<p id="Par10">A 48-year-old woman working in the Wuhan Union Hospital presented with an 8-day history of fever (37–38 °C) accompanied by chills, dry cough, myalgia, and fatigue. WBC count was within the reference range, but she had increased hsCRP levels (12.2 mg/L). A search for known respiratory pathogens yielded negative findings. Chest CT imaging (January 15, 2020, Fig.
<xref rid="Fig4" ref-type="fig">4d</xref>
) led to the identification of a blurry shadow in the right lower lung lobe. A subsequent
<sup>18</sup>
F-FDG PET/CT scan (January 20, 2020) revealed the presence of peripheral FDG-avid GGOs with interlobular septal thickening in both lungs (SUVmax range 3.7–9.3; Fig. 
<xref rid="Fig4" ref-type="fig">4a, b</xref>
, arrows). When compared with previous chest CT results, there was evidence of disease progression as shown by a higher number of lesions, which were also characterized by an increased extent and density. There were also multiple FDG-positive lymph nodes in the mediastinum and right hilar region (SUVmax range 3.8–5.5; Fig. 
<xref rid="Fig4" ref-type="fig">4c</xref>
, arrows). Real-time fluorescent polymerase chain reaction (RT-PCR) for the detection of SARS-CoV-2 nucleic acid yielded negative findings in two independent measurements. A follow-up chest CT (February 1, 2020) performed after antiviral and anti-infective treatment revealed a significant improvement in the picture (Fig. 
<xref rid="Fig4" ref-type="fig">4d</xref>
).
<fig id="Fig4">
<label>Fig. 4</label>
<caption>
<p>Peripheral FDG-avid GGOs with interlobular septal thickening in both lungs and multiple FDG-positive lymph nodes in the mediastinum and right hilar region</p>
</caption>
<graphic xlink:href="259_2020_4734_Fig4_HTML" id="MO4"></graphic>
</fig>
</p>
</sec>
<sec id="Sec1">
<title>Discussion</title>
<p id="Par11">Because COVID-19 is believed to have an interpersonal human-to-human transmission [
<xref ref-type="bibr" rid="CR2">2</xref>
], either home residence or a travel history to Wuhan—coupled with exposure to known or suspected cases—is paramount to raise clinical suspicion. The clinical, laboratory, and imaging characteristics of the four patients described in the current report are consistent with a diagnosis of COVID-19. Herein, we therefore describe for the first time the
<sup>18</sup>
F-FDG PET/CT findings of four patients with COVID-19.</p>
<p id="Par12">In accordance with previously published observations [
<xref ref-type="bibr" rid="CR5">5</xref>
,
<xref ref-type="bibr" rid="CR6">6</xref>
]
<bold>,</bold>
our cases were characterized by the presence of peripheral GGOs and/or consolidative opacities in more than two pulmonary lobes. Notably, all of these lesions showed a high tracer uptake. Although a bilateral involvement of the lung parenchyma can be observed in several benign and malignant lung diseases [
<xref ref-type="bibr" rid="CR7">7</xref>
]
<bold>,</bold>
tumors presenting as GGOs are unlikely to be FDG-avid [
<xref ref-type="bibr" rid="CR8">8</xref>
]
<bold>.</bold>
The high tracer uptake that characterized COVID-19 pulmonary infections reflects a significant inflammatory burden, similar to that elicited by the Middle East respiratory syndrome or the H1N1 pandemic influenza virus [
<xref ref-type="bibr" rid="CR9">9</xref>
,
<xref ref-type="bibr" rid="CR10">10</xref>
]
<bold>.</bold>
Although COVID-19 infections do not seem to be accompanied by lymphadenopathy [
<xref ref-type="bibr" rid="CR6">6</xref>
]
<bold>,</bold>
our
<sup>18</sup>
F-FDG PET/CT findings revealed an increased nodal FDG uptake in three of four cases. Although no obvious nodal enlargement was evident, our imaging data indicate for the first time that COVID-19 may cause lymphadenitis—in line with previous data obtained from non-human primates exposed to MERS-CoV [
<xref ref-type="bibr" rid="CR9">9</xref>
]
<bold>.</bold>
Another interesting finding is that no disseminated lesions were evident in our patients—suggesting that COVID-19 has pulmonary tropism.</p>
<p id="Par13">Although
<sup>18</sup>
F-FDG PET/CT cannot be routinely used in an emergency setting and is generally not recommended for infectious diseases, our current findings demonstrate that this imaging modality may play a complementary diagnostic role in COVID-19—especially at early stages when clinical symptoms are not specific and differential diagnosis is challenging.</p>
<p id="Par14">Our case series is limited by the small sample size and the lack of molecular confirmation of SARS-CoV-2 infection. However, only 30–50% of infected patients had positive test for SARS-CoV-2 nucleic acid on RT-PCR (Chinese Academy of Sciences; unpublished data). High rates of false-negative findings may be explained by several reasons, including (1) the lack of SOPs for SARS-CoV-2 nucleic acid detection, differences in sample handling, storage, and processing, (2) disease stages and different viral loads according to anatomical site (e.g., alveoli versus upper respiratory tract), (3) the lack of independent validation of current testing, and (4) the potential high mutation rates of COVID-19. In light of these limitations, some cases of COVID-19 in China are currently diagnosed on clinical, laboratory, and imaging grounds, without resorting to molecular confirmation.</p>
<p id="Par15">These caveats notwithstanding, we show for the first time that (1) lung lesions of patients with COVID-19 pneumonia are characterized by high
<sup>18</sup>
F-FDG uptake, (2) this condition is accompanied by nodal involvement detectable on
<sup>18</sup>
F-FDG PET/CT imaging, and (3) there is no evidence of disseminated disease, indicating that COVID-19 may have specific lung tropism.</p>
</sec>
</body>
<back>
<fn-group>
<fn>
<p>This article is part of the Topical Collection on Infection and inflammation</p>
</fn>
<fn>
<p>
<bold>Publisher’s note</bold>
</p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
</fn-group>
<notes notes-type="ethics">
<title>Compliance with ethical standards</title>
<notes notes-type="COI-statement">
<title>Conflict of interest</title>
<p id="Par16">The authors declare that they have no conflict of interest.</p>
</notes>
<notes>
<title>Research involving human participants and/or animals</title>
<p id="Par17">This retrospective study of existing patient data and images was approved by the institutional review board of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. The requirement for informed consent was waived.</p>
</notes>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>Na</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Dingyu</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Wenling</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Xingwang</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Bo</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Jingdong</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Xiang</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Baoying</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Weifeng</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Roujian</given-names>
</name>
<name>
<surname>Niu</surname>
<given-names>Peihua</given-names>
</name>
<name>
<surname>Zhan</surname>
<given-names>Faxian</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Xuejun</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Dayan</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Wenbo</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Guizhen</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>George F.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>Wenjie</given-names>
</name>
</person-group>
<article-title>A Novel Coronavirus from Patients with Pneumonia in China, 2019</article-title>
<source>New England Journal of Medicine</source>
<year>2020</year>
<volume>382</volume>
<issue>8</issue>
<fpage>727</fpage>
<lpage>733</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa2001017</pub-id>
<pub-id pub-id-type="pmid">31978945</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<mixed-citation publication-type="other">Centers for Disease Control and Prevention. 2019 Novel coronavirus, Wuhan, China: 2019-nCoV situation summary. January 28, 2020.
<ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-nCoV/summary.html">https://www.cdc.gov/coronavirus/2019-nCoV/summary.html</ext-link>
.</mixed-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<mixed-citation publication-type="other">Coronavirus latest: WHO officially names disease COVID-19. Nature News. February 11, 2020. https://
<ext-link ext-link-type="uri" xlink:href="http://www.nature.com/articles/d41586-020-00154-w">www.nature.com/articles/d41586-020-00154-w</ext-link>
.</mixed-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>Chaolin</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Yeming</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Xingwang</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>Lili</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Jianping</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Yi</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Li</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>Guohui</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Jiuyang</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>Xiaoying</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>Zhenshun</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Ting</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>Jiaan</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Yuan</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Wenjuan</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Xuelei</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>Wen</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Hui</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Min</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>Yan</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Hong</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Li</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Jungang</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Guangfa</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Rongmeng</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Zhancheng</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>Qi</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Jianwei</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Bin</given-names>
</name>
</person-group>
<article-title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</article-title>
<source>The Lancet</source>
<year>2020</year>
<volume>395</volume>
<issue>10223</issue>
<fpage>497</fpage>
<lpage>506</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(20)30183-5</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Nanshan</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Min</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Xuan</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>Jieming</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>Fengyun</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Yang</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>Yang</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Jingli</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Ying</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Yuan</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>Jia'an</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Ting</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Xinxin</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Li</given-names>
</name>
</person-group>
<article-title>Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study</article-title>
<source>The Lancet</source>
<year>2020</year>
<volume>395</volume>
<issue>10223</issue>
<fpage>507</fpage>
<lpage>513</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(20)30211-7</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<mixed-citation publication-type="other">Chung M, Bernheim A, Mei X, Zhang N, Huang M, Zeng X, et al. CT Imaging Features of 2019 Novel coronavirus (2019-nCoV). Radiology. 2020:200230. 10.1148/radiol.2020200230.</mixed-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prabhu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Raju</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chakraborty</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Arora</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Spectrum of 18F-FDG uptake in bilateral lung parenchymal diseases on PET/CT</article-title>
<source>Clin Nucl Med</source>
<year>2020</year>
<volume>45</volume>
<fpage>e15</fpage>
<lpage>ee9</lpage>
<pub-id pub-id-type="doi">10.1097/rlu.0000000000002758</pub-id>
<pub-id pub-id-type="pmid">31524673</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacobson</surname>
<given-names>FL</given-names>
</name>
<name>
<surname>Tarascio</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Fox</surname>
<given-names>SW</given-names>
</name>
</person-group>
<article-title>Can PET/CT help manage ground glass nodules?</article-title>
<source>J Surg Oncol</source>
<year>2018</year>
<volume>117</volume>
<fpage>457</fpage>
<lpage>458</lpage>
<pub-id pub-id-type="doi">10.1002/jso.24975</pub-id>
<pub-id pub-id-type="pmid">29473946</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chefer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Thomasson</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Seidel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Reba</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Bohannon</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Lackemeyer</surname>
<given-names>MG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Modeling [(18)F]-FDG lymphoid tissue kinetics to characterize nonhuman primate immune response to Middle East respiratory syndrome-coronavirus aerosol challenge</article-title>
<source>EJNMMI Res</source>
<year>2015</year>
<volume>5</volume>
<fpage>65</fpage>
<pub-id pub-id-type="doi">10.1186/s13550-015-0143-x</pub-id>
<pub-id pub-id-type="pmid">26573211</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jonsson</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Camp</surname>
<given-names>JV</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kraenzle</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Biller</surname>
<given-names>AE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular imaging reveals a progressive pulmonary inflammation in lower airways in ferrets infected with 2009 H1N1 pandemic influenza virus</article-title>
<source>PLoS One</source>
<year>2012</year>
<volume>7</volume>
<fpage>e40094</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0040094</pub-id>
<pub-id pub-id-type="pmid">22911695</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000070 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000070 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     PMC:7080035
   |texte=   18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i   -Sk "pubmed:32088847" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidV2 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021